Literature DB >> 27075767

Combined Therapy With Adipose-Derived Mesenchymal Stem Cells and Ciprofloxacin Against Acute Urogenital Organ Damage in Rat Sepsis Syndrome Induced by Intrapelvic Injection of Cecal Bacteria.

Pei-Hsun Sung1, Hsin-Ju Chiang2, Chih-Hung Chen3, Yi-Ling Chen1, Tien-Hung Huang1, Yen-Yi Zhen1, Meng-Wei Chang4, Chu-Feng Liu4, Sheng-Ying Chung1, Yung-Lung Chen1, Han-Tan Chai1, Cheuk-Kwan Sun5, Hon-Kan Yip6.   

Abstract

UNLABELLED: We hypothesized that combined treatment with autologous adipose-derived mesenchymal stem cell (ADMSC) and ciprofloxacin is superior to ciprofloxacin only in reducing sepsis-induced urogenital organ damage and mortality in rat sepsis syndrome (SS) caused by intrapelvic injection of cecal bacteria (1.0 × 10(4) cells per milliliter; total, 5.0 ml). Male Sprague-Dawley rats (n = 60) equally divided into group 1 (sham-control), group 2 (SS), group 3 (SS-ADMSC [5.0 × 10(5) intravenously at 0.5, 6, and 18 hours after sepsis induction]), group 4 (SS-ciprofloxacin [3.0 mg/kg, b.i.d.] for 5 days), and group 5 (SS-ADMSC-ciprofloxacin) were sacrificed by day 5. Mortality rate and creatinine level were highest in group 2 and lowest in group 1 and significantly higher in groups 3 and 4 than those in group 5, but there was no difference between groups 3 and 4 (all p < .005). The kidney injury score, inflammatory biomarker expressions at protein (tumor necrosis factor-1α, nuclear factor-κB, matrix metallopeptidase-9, regulated on activation, normal T-cell expressed and secreted, interleukin-1β) and cellular (CD14+, migratory inhibitor factor positive, CD68+) levels in kidneys and urinary bladder were lowest in group 1 and highest in group 2, higher in group 4 than in groups 3 and 5, and higher in group 3 than in group 5 (all p < .001). Protein expressions of apoptosis (Bax, cleaved caspase 3 and poly[ADP-ribose] polymerase 1, p21 protein [Cdc42/Rac]-activated kinase 2) and oxidative stress (oxidized protein, NADPH oxidase (NOX)-1, NOX-2) in these organs showed an identical pattern compared with that of inflammation in all groups (all p < .001). In conclusion, ADMSC-assisted ciprofloxacin therapy offered an additional benefit by reducing acute urogenital organ damage in rat. SIGNIFICANCE: Autologous adipose-derived mesenchymal stem cell-assisted ciprofloxacin therapy offered an additional benefit by reducing acute urogenital organ damage in rats. ©AlphaMed Press.

Entities:  

Keywords:  Adipose-derived mesenchymal stem cells; Antibiotics; Inflammation; Sepsis syndrome; Urogenital organ damage

Mesh:

Substances:

Year:  2016        PMID: 27075767      PMCID: PMC4878325          DOI: 10.5966/sctm.2015-0116

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  29 in total

1.  Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.

Authors:  Anna Krasnodembskaya; Gianluca Samarani; Yuanlin Song; Hanjing Zhuo; Xiao Su; Jae-Woo Lee; Naveen Gupta; Mario Petrini; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

Review 2.  The role of innate immunity in septic acute kidney injuries.

Authors:  Giselle Martins Gonçalves; Dario S Zamboni; Niels Olsen Saraiva Câmara
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

3.  Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia.

Authors:  Brent R Weil; Jeremy L Herrmann; Aaron M Abarbanell; Mariuxi C Manukyan; Jeffrey A Poynter; Daniel R Meldrum
Journal:  Shock       Date:  2011-09       Impact factor: 3.454

4.  Impact of the Surviving Sepsis Campaign on the recognition and management of severe sepsis in the emergency department: are we failing?

Authors:  Helen Lindsay Cronshaw; Ron Daniels; Anthony Bleetman; Emma Joynes; Mark Sheils
Journal:  Emerg Med J       Date:  2010-07-26       Impact factor: 2.740

5.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

6.  Use of a protocolized approach to the management of sepsis can improve time to first dose of antibiotics.

Authors:  Pamela S Tipler; Jeremy Pamplin; Vincent Mysliwiec; David Anderson; Cristin A Mount
Journal:  J Crit Care       Date:  2012-10-24       Impact factor: 3.425

7.  Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury.

Authors:  Hon-Kan Yip; Yi-Chih Chang; Christopher Glenn Wallace; Li-Teh Chang; Tzu-Hsien Tsai; Yung-Lung Chen; Hsueh-Wen Chang; Steve Leu; Yen-Yi Zhen; Ching-Yen Tsai; Kuo-Ho Yeh; Cheuk-Kwan Sun; Chia-Hung Yen
Journal:  J Pineal Res       Date:  2012-10-30       Impact factor: 13.007

8.  Defining the cause of death in hospitalised patients with acute kidney injury.

Authors:  Nicholas M Selby; Nitin V Kolhe; Christopher W McIntyre; John Monaghan; Nigel Lawson; David Elliott; Rebecca Packington; Richard J Fluck
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

9.  Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in rat sepsis syndrome induced by cecal puncture and ligation.

Authors:  Chia-Lo Chang; Steve Leu; Hsin-Ching Sung; Yen-Yi Zhen; Chung-Lung Cho; Angela Chen; Tzu-Hsien Tsai; Sheng-Ying Chung; Han-Tan Chai; Cheuk-Kwan Sun; Chia-Hung Yen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2012-12-07       Impact factor: 5.531

10.  Prediction of outcome from community-acquired severe sepsis and septic shock in tertiary-care university hospital in a developing country.

Authors:  Krsto Grozdanovski; Zvonko Milenkovic; Ilir Demiri; Katerina Spasovska
Journal:  Crit Care Res Pract       Date:  2012-10-17
View more
  16 in total

1.  Exendin-4-assisted adipose derived mesenchymal stem cell therapy protects renal function against co-existing acute kidney ischemia-reperfusion injury and severe sepsis syndrome in rat.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Christopher Glenn Wallace; Chih-Chao Yang; Yen-Ta Chen; Kuan-Hung Chen; Chih-Hung Chen; Pei-Lin Shao; Yung-Lung Chen; Sarah Chua; Han-Tan Chai; Yi-Ling Chen; Tien-Hung Huang; Hon-Kan Yip; Mel S Lee
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells.

Authors:  Tihomir Georgiev-Hristov; H Guadalajara; M D Herreros; A L Lightner; E J Dozois; M García-Arranz; D García-Olmo
Journal:  J Gastrointest Surg       Date:  2018-07-31       Impact factor: 3.452

3.  Adipose-derived mesenchymal stem cell-derived exosomes markedly protected the brain against sepsis syndrome induced injury in rat.

Authors:  Chia-Lo Chang; Hong-Hwa Chen; Kuan-Hung Chen; John Y Chiang; Yi-Chen Li; Hung-Sheng Lin; Pei-Hsun Sung; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

4.  Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections.

Authors:  Valerie Johnson; Tracy Webb; Annalis Norman; Jonathan Coy; Jade Kurihara; Daniel Regan; Steven Dow
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

5.  The effects of etomidate and midazolam on adipose tissue-derived mesenchymal stem cell proliferation.

Authors:  Ho Park; Kyoungho Ryu; Yun-Hong Kim; Won-Jun Choi; Dongchan Ko
Journal:  Korean J Anesthesiol       Date:  2016-09-08

6.  Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis.

Authors:  Fan-Yen Lee; Kuan-Hung Chen; Christopher Glenn Wallace; Pei-Hsun Sung; Jiunn-Jye Sheu; Sheng-Ying Chung; Yung-Lung Chen; Hung-I Lu; Sheung-Fat Ko; Cheuk-Kwan Sun; Hsin-Ju Chiang; Hsueh-Wen Chang; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-07-11

Review 7.  Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.

Authors:  Christian L Johnson; Yorick Soeder; Marc H Dahlke
Journal:  Stem Cells Transl Med       Date:  2017-01-09       Impact factor: 6.940

Review 8.  Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley?

Authors:  Jan Horák; Lukáš Nalos; Vendula Martínková; Jan Beneš; Milan Štengl; Martin Matějovič
Journal:  Stem Cells Int       Date:  2017-09-14       Impact factor: 5.443

9.  Combinational therapy with antibiotics and antibiotic-loaded adipose-derived stem cells reduce abscess formation in implant-related infection in rats.

Authors:  Junya Yoshitani; Tamon Kabata; Hiroshi Arakawa; Yukio Kato; Takayuki Nojima; Katsuhiro Hayashi; Masaharu Tokoro; Naotoshi Sugimoto; Yoshitomo Kajino; Daisuke Inoue; Ken Ueoka; Yuki Yamamuro; Hiroyuki Tsuchiya
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

10.  Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats.

Authors:  Chih-Hung Chen; Ben-Chung Cheng; Kuan-Hung Chen; Pei-Lin Shao; Pei-Hsun Sung; Hsin-Ju Chiang; Chih-Chao Yang; Kun-Chen Lin; Cheuk-Kwan Sun; Jiunn-Jye Sheu; Hsueh-Wen Chang; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.